FDA WARNING_LETTER - snusblast.co.uk

On July 2, 2026, the U.S. Food and Drug Administration (FDA) issued a warning letter to the United Kingdom-based company snusblast.co.uk. The letter follows an investigation into the company’s website, which determined that its nicotine pouch products are offered for sale and distribution to consumers within the United States. The primary violation identified was the sale of a tobacco product to an individual under the age of 21. Specifically, the FDA documented an instance where a minor successfully purchased Zyn Chili Guava X-Strong Nicotine Pouches (11mg) from the website. Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), it is strictly prohibited for any retailer to sell tobacco products—regardless of the nicotine source—to anyone under the legal age of 21. Consequently, the product is considered illegally marketed in the United States. The regulatory framework cited includes the FD&C Act and relevant federal regulations governing the sale, distribution, and premarket authorization of tobacco products. The FDA notified the company that failure to address these violations could lead to serious consequences, such as civil money penalties, product seizures, or the refusal of their products at the U.S. border. Snusblast.co.uk is required to provide a written response to the FDA within 15 working days. This response must outline the specific actions taken to correct the violations, the dates these changes were implemented, and the company’s plan to maintain compliance with federal law moving forward.